144 related articles for article (PubMed ID: 38151292)
1. Depletion of
Yoshizawa M; Shiozaki A; Ashihara E
Cancer Genomics Proteomics; 2024; 21(1):18-29. PubMed ID: 38151292
[TBL] [Abstract][Full Text] [Related]
2. [Effect of Hematopoietic Pre-B-cell Leukemia Transcription Factor Interacting Protein Knockdown on Proliferation,Cell Cycle and Apoptosis in Pancreatic Cancer Cells].
Zhao YM; Yang G; You L; Hu Y; Zhao YP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):7-15. PubMed ID: 32131934
[No Abstract] [Full Text] [Related]
3. HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis.
Chile T; Fortes MA; Corrêa-Giannella ML; Brentani HP; Maria DA; Puga RD; de Paula Vde J; Kubrusly MS; Novak EM; Bacchella T; Giorgi RR
BMC Cancer; 2013 Oct; 13():451. PubMed ID: 24088503
[TBL] [Abstract][Full Text] [Related]
4. [MiR-150-5p inhibits the proliferation and promoted apoptosis of pancreatic cancer cells].
Sun Y; Jin XL; Zhang TT; Jia CW; Chen J
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):460-4. PubMed ID: 24246865
[TBL] [Abstract][Full Text] [Related]
5. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
[TBL] [Abstract][Full Text] [Related]
6. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
[TBL] [Abstract][Full Text] [Related]
7. A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.
Li J; Ke J; Fang J; Chen JP
J Cell Biochem; 2020 Jan; 121(1):743-754. PubMed ID: 31478239
[TBL] [Abstract][Full Text] [Related]
8. Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitro.
Yamaguchi M; Osuka S; Weitzmann MN; El-Rayes BF; Shoji M; Murata T
Int J Oncol; 2016 May; 48(5):1955-64. PubMed ID: 26935290
[TBL] [Abstract][Full Text] [Related]
9. Suppression of human pancreatic cancer cell proliferation by AGN194204, an RXR-selective retinoid.
Balasubramanian S; Chandraratna RA; Eckert RL
Carcinogenesis; 2004 Aug; 25(8):1377-85. PubMed ID: 14976133
[TBL] [Abstract][Full Text] [Related]
10. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
[TBL] [Abstract][Full Text] [Related]
11. Effect of miR-184 on Proliferation and Apoptosis of Pancreatic Ductal Adenocarcinoma and Its Mechanism.
Li S; Li H; Ge W; Song K; Yuan C; Yin R
Technol Cancer Res Treat; 2020; 19():1533033820943237. PubMed ID: 32914707
[TBL] [Abstract][Full Text] [Related]
12. The NF-κB/miR-488/ERBB2 axis modulates pancreatic cancer cell malignancy and tumor growth through cell cycle signaling.
Han D; Zhu S; Li X; Li Z; Huang H; Gao W; Liu Y; Zhu H; Yu X
Cancer Biol Ther; 2022 Dec; 23(1):294-309. PubMed ID: 35343383
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Gemcitabine on Cell Cycle Arrest and microRNA Signatures in Pancreatic Cancer Cells.
Namima D; Fujihara S; Iwama H; Fujita K; Matsui T; Nakahara M; Okamura M; Hirata M; Kono T; Fujita N; Yamana H; Kato K; Kamada H; Morishita A; Kobara H; Tsutsui K; Masaki T
In Vivo; 2020; 34(6):3195-3203. PubMed ID: 33144424
[TBL] [Abstract][Full Text] [Related]
14. Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, G
Bi YL; Min M; Shen W; Liu Y
Phytomedicine; 2018 Jan; 39():10-16. PubMed ID: 29433670
[TBL] [Abstract][Full Text] [Related]
15. G2/M cell-cycle arrest and apoptosis by n-3 fatty acids in a pancreatic cancer model.
Dekoj T; Lee S; Desai S; Trevino J; Babcock TA; Helton WS; Espat NJ
J Surg Res; 2007 May; 139(1):106-12. PubMed ID: 17291531
[TBL] [Abstract][Full Text] [Related]
16. Claudin 7 as a possible novel molecular target for the treatment of pancreatic cancer.
Okui N; Kamata Y; Sagawa Y; Kuhara A; Hayashi K; Uwagawa T; Homma S; Yanaga K
Pancreatology; 2019 Jan; 19(1):88-96. PubMed ID: 30416041
[TBL] [Abstract][Full Text] [Related]
17. SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation.
Chen Z; Li Z; Li W; Zong Y; Zhu Y; Miao Y; Xu Z
Dig Dis Sci; 2015 Nov; 60(11):3304-17. PubMed ID: 26108419
[TBL] [Abstract][Full Text] [Related]
18. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M
Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718
[TBL] [Abstract][Full Text] [Related]
19. Synergistic Anticancer Effects of Gemcitabine with Pitavastatin on Pancreatic Cancer Cell Line MIA PaCa-2 in vitro and in vivo.
Chen YH; Chen YC; Lin CC; Hsieh YP; Hsu CS; Hsieh MC
Cancer Manag Res; 2020; 12():4645-4665. PubMed ID: 32606957
[TBL] [Abstract][Full Text] [Related]
20. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo.
Han X; Kuang T; Ren Y; Lu Z; Liao Q; Chen W
Exp Cell Res; 2019 Dec; 385(1):111605. PubMed ID: 31493385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
